| Organization's Mission Statement: Since its founding in 1994, Kyphon has been dedicated to improving patient quality of life through revolutionizing the practice of medicine. Kyphon's mission is to be the recognized global leader in restoring spinal function through minimally invasive therapies.
According to the National Osteoporosis Foundation, each year 700,000 patients--primarily women--suffer vertebral compression fractures (VCFs) due to osteoporosis in the U.S. alone. Unfortunately, over 400,000 of these fractures go undiagnosed and untreated due in part to lack of awareness about osteoporosis and available treatment options. Left unattended, many fractures can result in an exaggerated rounded curvature of the spine, called kyphosis or "dowager's hump." This condition is painful and debilitating - making walking, eating, sleeping and even breathing painful and difficult.
Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive technology. The Company's products are used in Balloon Kyphoplasty, a minimally invasive procedure to treat spinal fractures (also known as vertebral compression fractures or VCFs) caused by osteoporosis. The procedure, which generally takes less than one hour to treat each fracture, is designed to repair vertebral compression fractures and restore the vertebrae to the correct position, reducing back pain, reducing the number of days in bed, significantly improving mobility and increasing overall quality of life. In most cases, Medicare provides coverage for kyphoplasty. Other insurance may also provide coverage. To date, over 85,000 fractures in 70,000 patients worldwide have been treated with Balloon Kyphoplasty.
For more information, visit the company's web site at http://www.kyphon.com.
|
